scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1031916379 |
P356 | DOI | 10.1186/S12933-016-0400-Y |
P8608 | Fatcat ID | release_7pmedjtzyjgqll6hwvy3lj3qw4 |
P932 | PMC publication ID | 4882784 |
P698 | PubMed publication ID | 27229923 |
P50 | author | Martin Bødtker Mortensen | Q55856237 |
P2093 | author name string | Erling Falk | |
Imra Kulenovic | |||
P2860 | cites work | European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice | Q49154329 |
The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. | Q50558006 | ||
Statin use prior to first myocardial infarction in contemporary patients: Inefficient and not gender equitable | Q86944045 | ||
??? | Q22242898 | ||
Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 | ||
Active Smoking and the Risk of Type 2 Diabetes | Q22252990 | ||
Standards of Medical Care in Diabetes--2015: Summary of Revisions | Q22255451 | ||
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies | Q24608301 | ||
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction | Q28195833 | ||
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q29620108 | ||
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial | Q29622926 | ||
Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction | Q30576479 | ||
Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus | Q33961763 | ||
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial | Q33966645 | ||
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). | Q34196167 | ||
Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction. | Q34364949 | ||
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab | Q34368081 | ||
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial | Q34822871 | ||
In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000-2010 | Q35026397 | ||
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial | Q35106580 | ||
Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus | Q35128612 | ||
Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registry | Q35402231 | ||
Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imaging | Q36071862 | ||
The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study. | Q36076136 | ||
Smoking in diabetic nephropathy: sparks in the fuel tank? | Q38072702 | ||
Revisiting the links between glycaemia, diabetes and cardiovascular disease | Q38077060 | ||
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials | Q38093098 | ||
Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). | Q38199288 | ||
Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study | Q39918625 | ||
Low statin use in adults hospitalized with acute coronary syndrome | Q40904895 | ||
Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications | Q42537111 | ||
Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. | Q43427221 | ||
Improved quality of Type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trial | Q43783493 | ||
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis | Q46810855 | ||
Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy). | Q46822432 | ||
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted | Q48527068 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 81 | |
P577 | publication date | 2016-05-27 | |
P1433 | published in | Cardiovascular Diabetology | Q2468083 |
P1476 | title | Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction | |
P478 | volume | 15 |
Q55516148 | Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. |
Q37737452 | Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study |
Q41494768 | Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study |
Q91750804 | Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia |
Q47119196 | Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II). |
Search more.